DISTRIBUTION, MANUFACTURING, AND LICENSE AGREEMENTDistribution, Manufacturing, and License Agreement • April 1st, 2005 • Acambis PLC • Pharmaceutical preparations • England and Wales
Contract Type FiledApril 1st, 2005 Company Industry JurisdictionThis Distribution, Manufacturing, and License Agreement is entered into at the date of countersignature (the “Effective Date”) by and between Acambis Research Limited, Peterhouse Technology Park, 100 Fulbourn Road, Cambridge CB1 9PT UK (“Acambis Research”) and Baxter Healthcare SA, having offices at Hertistrasse 2, CH-8304 Wallisellen, Switzerland (“BHSA”) and Baxter Healthcare Corporation, having offices at One Baxter Parkway, Deerfield, IL 60015 (“BHC”).
DISTRIBUTION, MANUFACTURING AND LICENSE AGREEMENTDistribution, Manufacturing and License Agreement • August 9th, 2001 • Quicklogic Corporation • Semiconductors & related devices • California
Contract Type FiledAugust 9th, 2001 Company Industry JurisdictionTHIS DISTRIBUTION, MANUFACTURING, AND LICENSE AGREEMENT (the "Agreement") is made and entered into as of this 17th day of April, 2001 (the "Effective Date") by and between QuickLogic Corporation, a Delaware corporation ("QuickLogic"), V3 Semiconductor, Inc., a Nevada corporation ("V3 Semiconductor") and V3 Semiconductor, Corp., an Ontario corporation ("V3 Canada"). V3 Semiconductor and V3 Canada shall be collectively referred to as "V3". Each of QuickLogic and V3 are hereafter referred to as a "Party"; and together hereafter referred to as the "Parties".
DISTRIBUTION, MANUFACTURING, AND LICENSE AGREEMENTDistribution, Manufacturing, and License Agreement • July 16th, 2003 • Acambis PLC • Pharmaceutical preparations • England and Wales
Contract Type FiledJuly 16th, 2003 Company Industry JurisdictionThis Distribution, Manufacturing, and License Agreement is entered into at the date of countersignature (the “Effective Date”) by and between Acambis Research Limited, Peterhouse Technology Park, 100 Fulbourn Road, Cambridge CB1 9PT UK (“Acambis Research”) and Baxter Healthcare SA, having offices at Hertistrasse 2, CH-8304 Wallisellen, Switzerland (“BHSA”) and Baxter Healthcare Corporation, having offices at One Baxter Parkway, Deerfield, IL 60015 (“BHC”).